Peripheral Causes of Neurodegeneration

Neurodegenerative diseases may be caused in part by triggers from peripheral body systems or inflammation mediated by brain cells other than neurons. Understanding these peripheral factors is necessary for designing treatments. Additionally, genetic tools allowing for delivery of transgenes past the blood-brain barrier are important for treatments of any CNS diseases. Discover the latest research on neurodegenerative disorders, their peripheral causes, and viral vectors for CNS delivery here.

December 7, 2021

Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract.

Fei-Yang TzouChih-Chiang Chan
December 6, 2021

A Comprehensive Review of Neuronal Changes in Diabetics.

Rudy LunaFenil Gandhi
December 6, 2021
Open Access

Anti-Inflammatory and Anti-Oxidative Effects of AM404 in IL-1β-Stimulated SK-N-SH Neuroblastoma Cells.

Frontiers in Pharmacology
Matthias ApweilerBernd L Fiebich
December 6, 2021
Open Access

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson's Disease.

Frontiers in Aging Neuroscience
Chao GuMei Wang
December 6, 2021

Local and remote interactions between macrophages and microglia in neurological conditions.

Current Opinion in Immunology
Séverine Boillée
December 4, 2021
Open Access

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease.

Parkinson's Disease
Jianshe WeiMakoto Hashimoto
December 3, 2021

Neuroinflammation in Huntington's disease: A starring role for astrocyte and microglia.

Current Neuropharmacology
Julieta SabaCarla Caruso
December 3, 2021

The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function.

Redox Biology
Céline JaillardThierry Léveillard
December 2, 2021

Metalloproteinases and their inhibitors in neurological disease.

Naunyn-Schmiedeberg's Archives of Pharmacology
Edgar R Lopez-Navarro, Jose Gutierrez
December 2, 2021

The HERC proteins and the nervous system.

Seminars in Cell & Developmental Biology
Eva M Pérez-VillegasJose Luis Rosa
December 2, 2021

Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.

Pharmacology & Therapeutics
Tomás R GuilarteDiana J Azzam
December 1, 2021

Inflammasome activation in neurodegenerative diseases.

Essays in Biochemistry
Kishore Aravind Ravichandran, Michael T Heneka
November 29, 2021

The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Xiangqian LiuSulie L Chang
November 29, 2021

Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases.

Journal of Biochemical and Molecular Toxicology
Uzini Devi DaimaryAjaikumar B Kunnumakkara
November 29, 2021

A MDS Evidence-Based Review on Treatments for Huntington's Disease.

Movement Disorders : Official Journal of the Movement Disorder Society
Joaquim J FerreiraCristina Sampaio
November 29, 2021

Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters.

ACS Chemical Neuroscience
Mahtab AmiriZhila Izadi
November 29, 2021

Updates on the Genetics of Parkinson's Disease: Clinical Implications and Future Treatment.

Acta Neurologica Taiwanica
Yung-Tsai ChuRuey-Meei Wu

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved